Evidence map›Paper›PMID 42764396›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Compensatory Mitophagy via NEDD4/HIF-1α/BNIP3 Pathway Restrains EndMT and Renal Allograft Interstitial Fibrosis Induced by TNFα.

Dengyuan Feng, Qinghuan Shen, Junqi Zhang, Jiawen Liu, Zeping Gui, Zijie Wang, Qianguang Han, Shuang Fei, Hao Chen, Li Sun and 6 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Dengyuan FengDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Qinghuan ShenDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Junqi ZhangDepartment of Urology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jiawen LiuDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Zeping GuiDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Zijie WangDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Qianguang HanDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Shuang FeiDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Hao ChenDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Li SunDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Jun TaoDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Zhijian HanDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Xiaobing JuDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Min GuDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Jianjian ZhangDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Ruoyun TanDepartment of Urology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0009-0001-5052-5011

Funding

"333 High Level Talents Project" in Jiangsu Province BRA2016514"333 High Level Talents Project" in Jiangsu Province BRA2017532China Postdoctoral Science Foundation 2025M772005Jiangsu Province Natural Science Foundation Program BK20241129Jiangsu Province Natural Science Foundation Program BK20250225National Natural Science Foundation of China 81770751National Natural Science Foundation of China 81870512National Natural Science Foundation of China 81900684National Natural Science Foundation of China 82070769National Natural Science Foundation of China 82270790National Natural Science Foundation of China 82400889National Natural Science Foundation of China 82570887Postgraduate Research & Practice Innovation Program of Jiangsu Province KYCX24_2049
6 · The paper itself

Abstract

Renal allograft interstitial fibrosis/tubular atrophy (IF/TA) is the pathological hallmark of chronic renal allograft dysfunction (CAD) and endothelial-to-mesenchymal transition (EndMT) has been implicated as one of the key triggering factors. Here, we identified tumor necrosis factor-α (TNFα) as a key inducer of mitochondrial dysfunction and EndMT in endothelial cells of renal allografts. Importantly, TNFα simultaneously activated BNIP3-dependent mitophagy as a compensatory response, which removed damaged mitochondria, restrained EndMT, and attenuated renal allograft interstitial fibrosis. In addition, inhibition of BNIP3 promoted the accumulation of damaged mitochondria, aggravated EndMT, and exacerbated renal allograft interstitial fibrosis, supporting a protective role of mitophagy. Mechanistically, TNFα upregulated and stabilized HIF-1α by disrupting its NEDD4-mediated ubiquitination, thereby enhancing BNIP3 transcription to drive mitophagy. Moreover, endothelial-specific deletion of HIF-1α impaired this compensatory pathway, aggravated mitochondrial dysfunction, and exacerbated renal allograft interstitial fibrosis. Thus, compensatory mitophagy through the NEDD4/HIF-1α/BNIP3 pathway represented a potential protective stress-adaptation program in renal allograft endothelial cells, providing mechanistic insight and a conceptual framework for future therapeutic exploration aimed at preserving renal allograft function.

Indexed as

EndMTmitophagyNEDD4renal allograft interstitial fibrosisTNFα

Identifiers

PMID42764396
PMCPMC13590865

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.